Analogic (NASDAQ: ALOG) reported Q4 EPS of $1.02, $0.15 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $138 million versus the consensus estimate of $139.03 million.

For fiscal 2017, revenue is expected to grow mid-single digits with continued non-GAAP operating margin expansion targeting approximately 1 point resulting in non-GAAP earnings growth of 10% to 14%.

• Ultrasound is expected to grow in the mid teens with improving non-GAAP operating margins to the mid-single digits driven by strong double-digit growth in direct systems sales. Legacy OEM probe revenue is expected to stabilize at approximately $12 million for the year.
• Medical Imaging is expected to be roughly flat with continued high-teens, non-GAAP operating margins driven by Highly Ruggedized CT system growth in China. Mammography detector growth will be offset by MRI.
• Security and Detection returns to double-digit growth with mid-teens non-GAAP operating margin driven by a strengthening outlook for international high-speed tenders coupled with improving revenue run-rate for medium-speed systems for U.S.

For earnings history and earnings-related data on Analogic (ALOG) click here.